Automated cell counters are laboratory instruments used to count, classify and analyze cells in bodily fluids or other liquid samples. These cell counters offer advantages such as high accuracy, consistency and reproducibility of cell counts along with capability to analyze multi-parametric data. The growing prevalence of diseases requiring cell counting enhances the need for automated cell counters in the healthcare sector.
Market key trends:
Adoption of microfluidic cell counting technology is one of the key trends witnessed in the automated cell counters market. The microfluidic cell counters offer enhanced accuracy, sensitivity and robustness over conventional cell counters. They utilize microfluidic chips and precise fluid control to monitor cells flowing in miniature fluidic channels. The integration of microfluidics enables analysis of small volume samples and portability of instruments. This technology provides real time data at single cell resolution making it ideal for hematological and oncology applications. The development of easy to use, compact and affordable microfluidic cell counters augurs well for the overall market growth over the forecast period.
The global Automated Cell Counters Market Growth is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Strength: Automated cell counters provide accurate, fast and reproducible test results compared to manual cell counting. They eliminate human errors and variations.
Weakness: High initial costs associated with automated cell counters can be prohibitive for small laboratories and research facilities. Technical issues and maintenance requirements also add to the costs.
Opportunity: Rising prevalence of diseases like cancer is fuelling demand for advanced diagnostic techniques. This provides opportunities for vendors to develop more affordable automated cell counting solutions.
Threats: Strict regulatory approvals and standards delays market entry of new products. Economic slowdowns can negatively impact capital expenditures of research labs and healthcare facilities.
The global Automated Cell Counters market is expected to witness high growth, exhibiting a CAGR of 7.0% over the forecast period, due to increasing demand for disease diagnostics and drug discovery activities.
Market size: The global automated cell counters market size was valued at US$ 3.75 Bn in 2023 and is expected to reach over US$ 6.25 Bn by 2030. North America dominated the market in 2023 with over 35% market share owing to technological advancements and availability of favorable health insurance in the region.
Regional analysis: Asia Pacific is expected to be the fastest growing market during the forecast period driven by rising healthcare expenditures, infections, and cancers. Countries like China, India, and Japan are expected to boost the regional market growth.
Key players: Key players operating in the automated cell counters market include Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, Tecan, and Sartorius AG. Players are focusing on new product launches, partnerships, and geographic expansions to strengthen their market position.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it